Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Safe Insulin Syringes Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4696978
    • |
  • 21 May, 2026
    • |
  • Global
    • |
  • 131 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Safe Insulin Syringes market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Safe Insulin Syringes market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Safe Insulin Syringes market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Safe Insulin Syringes market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Safe Insulin Syringes market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Safe Insulin Syringes market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Safe Insulin Syringes
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Safe Insulin Syringes market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Accutome, B. Braun, Biocon Ltd, Ypsomed AG, BD, Abbott Laboratories, Novo Nordisk, F. Hoffmann-La Roche, AlShifa, Terumo, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Safe Insulin Syringes market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Reusable
Single Use
Market segment by Application
Hospital
Clinic
Others
Major players covered
Accutome
B. Braun
Biocon Ltd
Ypsomed AG
BD
Abbott Laboratories
Novo Nordisk
F. Hoffmann-La Roche
AlShifa
Terumo
Hunan Pingan Medical Devices
Zhejiang Kindly Medical Devices
Medtronic Plc
Sanofi
Wockhardt Ltd
HTL-Strefa
Animas Corporation
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Safe Insulin Syringes product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Safe Insulin Syringes, with price, sales quantity, revenue, and global market share of Safe Insulin Syringes from 2021 to 2026.
Chapter 3, the Safe Insulin Syringes competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Safe Insulin Syringes breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Safe Insulin Syringes market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Safe Insulin Syringes.
Chapter 14 and 15, to describe Safe Insulin Syringes sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Safe Insulin Syringes Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Reusable
    • 1.3.3 Single Use
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Safe Insulin Syringes Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Safe Insulin Syringes Market Size & Forecast
    • 1.5.1 Global Safe Insulin Syringes Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Safe Insulin Syringes Sales Quantity (2021-2032)
    • 1.5.3 Global Safe Insulin Syringes Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Accutome
    • 2.1.1 Accutome Details
    • 2.1.2 Accutome Major Business
    • 2.1.3 Accutome Safe Insulin Syringes Product and Services
    • 2.1.4 Accutome Safe Insulin Syringes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Accutome Recent Developments/Updates
  • 2.2 B. Braun
    • 2.2.1 B. Braun Details
    • 2.2.2 B. Braun Major Business
    • 2.2.3 B. Braun Safe Insulin Syringes Product and Services
    • 2.2.4 B. Braun Safe Insulin Syringes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 B. Braun Recent Developments/Updates
  • 2.3 Biocon Ltd
    • 2.3.1 Biocon Ltd Details
    • 2.3.2 Biocon Ltd Major Business
    • 2.3.3 Biocon Ltd Safe Insulin Syringes Product and Services
    • 2.3.4 Biocon Ltd Safe Insulin Syringes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Biocon Ltd Recent Developments/Updates
  • 2.4 Ypsomed AG
    • 2.4.1 Ypsomed AG Details
    • 2.4.2 Ypsomed AG Major Business
    • 2.4.3 Ypsomed AG Safe Insulin Syringes Product and Services
    • 2.4.4 Ypsomed AG Safe Insulin Syringes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Ypsomed AG Recent Developments/Updates
  • 2.5 BD
    • 2.5.1 BD Details
    • 2.5.2 BD Major Business
    • 2.5.3 BD Safe Insulin Syringes Product and Services
    • 2.5.4 BD Safe Insulin Syringes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 BD Recent Developments/Updates
  • 2.6 Abbott Laboratories
    • 2.6.1 Abbott Laboratories Details
    • 2.6.2 Abbott Laboratories Major Business
    • 2.6.3 Abbott Laboratories Safe Insulin Syringes Product and Services
    • 2.6.4 Abbott Laboratories Safe Insulin Syringes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Abbott Laboratories Recent Developments/Updates
  • 2.7 Novo Nordisk
    • 2.7.1 Novo Nordisk Details
    • 2.7.2 Novo Nordisk Major Business
    • 2.7.3 Novo Nordisk Safe Insulin Syringes Product and Services
    • 2.7.4 Novo Nordisk Safe Insulin Syringes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Novo Nordisk Recent Developments/Updates
  • 2.8 F. Hoffmann-La Roche
    • 2.8.1 F. Hoffmann-La Roche Details
    • 2.8.2 F. Hoffmann-La Roche Major Business
    • 2.8.3 F. Hoffmann-La Roche Safe Insulin Syringes Product and Services
    • 2.8.4 F. Hoffmann-La Roche Safe Insulin Syringes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 F. Hoffmann-La Roche Recent Developments/Updates
  • 2.9 AlShifa
    • 2.9.1 AlShifa Details
    • 2.9.2 AlShifa Major Business
    • 2.9.3 AlShifa Safe Insulin Syringes Product and Services
    • 2.9.4 AlShifa Safe Insulin Syringes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 AlShifa Recent Developments/Updates
  • 2.10 Terumo
    • 2.10.1 Terumo Details
    • 2.10.2 Terumo Major Business
    • 2.10.3 Terumo Safe Insulin Syringes Product and Services
    • 2.10.4 Terumo Safe Insulin Syringes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Terumo Recent Developments/Updates
  • 2.11 Hunan Pingan Medical Devices
    • 2.11.1 Hunan Pingan Medical Devices Details
    • 2.11.2 Hunan Pingan Medical Devices Major Business
    • 2.11.3 Hunan Pingan Medical Devices Safe Insulin Syringes Product and Services
    • 2.11.4 Hunan Pingan Medical Devices Safe Insulin Syringes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Hunan Pingan Medical Devices Recent Developments/Updates
  • 2.12 Zhejiang Kindly Medical Devices
    • 2.12.1 Zhejiang Kindly Medical Devices Details
    • 2.12.2 Zhejiang Kindly Medical Devices Major Business
    • 2.12.3 Zhejiang Kindly Medical Devices Safe Insulin Syringes Product and Services
    • 2.12.4 Zhejiang Kindly Medical Devices Safe Insulin Syringes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Zhejiang Kindly Medical Devices Recent Developments/Updates
  • 2.13 Medtronic Plc
    • 2.13.1 Medtronic Plc Details
    • 2.13.2 Medtronic Plc Major Business
    • 2.13.3 Medtronic Plc Safe Insulin Syringes Product and Services
    • 2.13.4 Medtronic Plc Safe Insulin Syringes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Medtronic Plc Recent Developments/Updates
  • 2.14 Sanofi
    • 2.14.1 Sanofi Details
    • 2.14.2 Sanofi Major Business
    • 2.14.3 Sanofi Safe Insulin Syringes Product and Services
    • 2.14.4 Sanofi Safe Insulin Syringes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Sanofi Recent Developments/Updates
  • 2.15 Wockhardt Ltd
    • 2.15.1 Wockhardt Ltd Details
    • 2.15.2 Wockhardt Ltd Major Business
    • 2.15.3 Wockhardt Ltd Safe Insulin Syringes Product and Services
    • 2.15.4 Wockhardt Ltd Safe Insulin Syringes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Wockhardt Ltd Recent Developments/Updates
  • 2.16 HTL-Strefa
    • 2.16.1 HTL-Strefa Details
    • 2.16.2 HTL-Strefa Major Business
    • 2.16.3 HTL-Strefa Safe Insulin Syringes Product and Services
    • 2.16.4 HTL-Strefa Safe Insulin Syringes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 HTL-Strefa Recent Developments/Updates
  • 2.17 Animas Corporation
    • 2.17.1 Animas Corporation Details
    • 2.17.2 Animas Corporation Major Business
    • 2.17.3 Animas Corporation Safe Insulin Syringes Product and Services
    • 2.17.4 Animas Corporation Safe Insulin Syringes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Animas Corporation Recent Developments/Updates

3 Competitive Environment: Safe Insulin Syringes by Manufacturer

  • 3.1 Global Safe Insulin Syringes Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Safe Insulin Syringes Revenue by Manufacturer (2021-2026)
  • 3.3 Global Safe Insulin Syringes Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Safe Insulin Syringes by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Safe Insulin Syringes Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Safe Insulin Syringes Manufacturer Market Share in 2025
  • 3.5 Safe Insulin Syringes Market: Overall Company Footprint Analysis
    • 3.5.1 Safe Insulin Syringes Market: Region Footprint
    • 3.5.2 Safe Insulin Syringes Market: Company Product Type Footprint
    • 3.5.3 Safe Insulin Syringes Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Safe Insulin Syringes Market Size by Region
    • 4.1.1 Global Safe Insulin Syringes Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Safe Insulin Syringes Consumption Value by Region (2021-2032)
    • 4.1.3 Global Safe Insulin Syringes Average Price by Region (2021-2032)
  • 4.2 North America Safe Insulin Syringes Consumption Value (2021-2032)
  • 4.3 Europe Safe Insulin Syringes Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Safe Insulin Syringes Consumption Value (2021-2032)
  • 4.5 South America Safe Insulin Syringes Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Safe Insulin Syringes Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Safe Insulin Syringes Sales Quantity by Type (2021-2032)
  • 5.2 Global Safe Insulin Syringes Consumption Value by Type (2021-2032)
  • 5.3 Global Safe Insulin Syringes Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Safe Insulin Syringes Sales Quantity by Application (2021-2032)
  • 6.2 Global Safe Insulin Syringes Consumption Value by Application (2021-2032)
  • 6.3 Global Safe Insulin Syringes Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Safe Insulin Syringes Sales Quantity by Type (2021-2032)
  • 7.2 North America Safe Insulin Syringes Sales Quantity by Application (2021-2032)
  • 7.3 North America Safe Insulin Syringes Market Size by Country
    • 7.3.1 North America Safe Insulin Syringes Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Safe Insulin Syringes Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Safe Insulin Syringes Sales Quantity by Type (2021-2032)
  • 8.2 Europe Safe Insulin Syringes Sales Quantity by Application (2021-2032)
  • 8.3 Europe Safe Insulin Syringes Market Size by Country
    • 8.3.1 Europe Safe Insulin Syringes Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Safe Insulin Syringes Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Safe Insulin Syringes Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Safe Insulin Syringes Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Safe Insulin Syringes Market Size by Region
    • 9.3.1 Asia-Pacific Safe Insulin Syringes Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Safe Insulin Syringes Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Safe Insulin Syringes Sales Quantity by Type (2021-2032)
  • 10.2 South America Safe Insulin Syringes Sales Quantity by Application (2021-2032)
  • 10.3 South America Safe Insulin Syringes Market Size by Country
    • 10.3.1 South America Safe Insulin Syringes Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Safe Insulin Syringes Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Safe Insulin Syringes Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Safe Insulin Syringes Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Safe Insulin Syringes Market Size by Country
    • 11.3.1 Middle East & Africa Safe Insulin Syringes Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Safe Insulin Syringes Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Safe Insulin Syringes Market Drivers
  • 12.2 Safe Insulin Syringes Market Restraints
  • 12.3 Safe Insulin Syringes Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Safe Insulin Syringes and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Safe Insulin Syringes
  • 13.3 Safe Insulin Syringes Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Safe Insulin Syringes Typical Distributors
  • 14.3 Safe Insulin Syringes Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Safe Insulin Syringes. Industry analysis & Market Report on Safe Insulin Syringes is a syndicated market report, published as Global Safe Insulin Syringes Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Safe Insulin Syringes market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo